-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 2, 2019, China's original treatment of Alzheimer's disease new drug "Phase 9 1" Glyuit sodium capsule, code-named: GV-971, English name: Sodium Oligomannate) officially launched in China, this is the Chinese scientists for 22 years of original research and development, Chinese enterprises, with full independent intellectual property rights to treat Alzheimer's new drugs, is also the world's first target brain-intestinal new drug treatment.
exploring the pathogenesis of Alzheimer's disease, more and more researchers are exploring the link between intestinal microbiome disorders, pathogenic groups, and Alzheimer's disease pathogens. After years of research and exploration, the
Phase 9 1 research team successfully completed Phase 3 clinical studies, proving that Phase 91 can improve cognitive function by reshaping the balance of the intestinal flora, inhibiting the abnormal increase of specific metabolites of the intestinal flora, reducing peripheral and central nervous inflammation, and reducing the deposition of a beta protein in the brain and excessive phosphorylation of Tau protein.
reporters learned that a total of 1199 subjects participated in the nine phase i, II, III clinical trial research.
3-phase clinical results over a 36-week period showed that phase 9 1 significantly improved cognitive function in patients with mild and moderate Alzheimer's disease.
the main therapeutic indicators improved cognitive function compared to the placebo group, the cognitive function scale score improved by 2.54 points (p.lt; 0.0001), and the rate of adverse event events was comparable to that of the placebo group.
nine issue son of prescription drugs, the vast number of patients can rely on doctor's prescription, the country's major professional pharmacies (DTP pharmacy) to buy nine-phase one capsule, the current specifications of 150mg x 14 capsules x 3 plate a box of pricing for 895 yuan.
according to the drug specification, the cost in January is about 3580 yuan, the cost of one year is about 40,000 yuan.
However, due to the patient's condition, the specific amount of medicine needs to be determined by the doctor at its discretion.
.
